citric acid, anhydrous has been researched along with Vomiting in 9 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Participants in a population-based colorectal cancer screening program using the fecal immunochemical test who were scheduled for a colonoscopy from 09:00 a." | 6.80 | Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial. ( Balaguer, F; Carballal, S; Cárdenas, A; Castells, A; del Manzano, S; Fernández-Esparrach, G; Ginés, A; González-Suárez, B; Grau, J; Llach, J; López-Cerón, M; Moreira, L; Ordás, I; Pellisé, M; Pozo, A; Ricart, E; Rodríguez de Miguel, C; Sendino, O; Serradesanferm, A; Ubré, M; Vaquero, EC, 2015) |
| "Participants in a population-based colorectal cancer screening program using the fecal immunochemical test who were scheduled for a colonoscopy from 09:00 a." | 2.80 | Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial. ( Balaguer, F; Carballal, S; Cárdenas, A; Castells, A; del Manzano, S; Fernández-Esparrach, G; Ginés, A; González-Suárez, B; Grau, J; Llach, J; López-Cerón, M; Moreira, L; Ordás, I; Pellisé, M; Pozo, A; Ricart, E; Rodríguez de Miguel, C; Sendino, O; Serradesanferm, A; Ubré, M; Vaquero, EC, 2015) |
| "The goal of this observational retrospective study was to evaluate various donor and procedural variables as potential risk factors for different types of moderate to severe adverse events (AEs) during apheresis collections." | 2.46 | Moderate and severe adverse events associated with apheresis donations: incidences and risk factors. ( Goldfinger, D; Lu, Q; Smeltzer, B; Yuan, S; Ziman, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, AM | 1 |
| Styres, C | 1 |
| Straatmann, C | 1 |
| Freedman, SB | 1 |
| Thull-Freedman, J | 1 |
| Rumantir, M | 1 |
| Eltorki, M | 1 |
| Schuh, S | 1 |
| Rodríguez de Miguel, C | 1 |
| Serradesanferm, A | 1 |
| López-Cerón, M | 1 |
| Carballal, S | 1 |
| Pozo, A | 1 |
| Balaguer, F | 1 |
| Cárdenas, A | 1 |
| Fernández-Esparrach, G | 1 |
| Ginés, A | 1 |
| González-Suárez, B | 1 |
| Moreira, L | 1 |
| Ordás, I | 1 |
| Ricart, E | 1 |
| Sendino, O | 1 |
| Vaquero, EC | 1 |
| Ubré, M | 1 |
| del Manzano, S | 1 |
| Grau, J | 1 |
| Llach, J | 1 |
| Castells, A | 1 |
| Pellisé, M | 1 |
| Yuan, S | 1 |
| Ziman, A | 1 |
| Smeltzer, B | 1 |
| Lu, Q | 1 |
| Goldfinger, D | 1 |
| Fukuda, T | 1 |
| Toyoshima, S | 1 |
| Nakashima, Y | 1 |
| Koshitani, O | 1 |
| Kawaguchi, Y | 1 |
| Momii, A | 1 |
| Burns, RA | 1 |
| Milner, JA | 1 |
| Corbin, JE | 1 |
| James, LP | 1 |
| Nichols, MH | 1 |
| King, WD | 1 |
| Palmer, AW | 1 |
| Waugaman, WR | 1 |
| Conklin, KA | 1 |
| Kotelko, DM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED Focused on the Prevention of RRT-related Hypophosphatemia and Optimization of Acid-base Balance: a Pilot Study[NCT03976440] | 30 participants (Anticipated) | Observational | 2019-06-01 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for citric acid, anhydrous and Vomiting
| Article | Year |
|---|---|
Moderate and severe adverse events associated with apheresis donations: incidences and risk factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arrhythmias, Cardiac; Blood Component Re | 2010 |
4 trials available for citric acid, anhydrous and Vomiting
| Article | Year |
|---|---|
Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial.
Topics: Aged; Ascorbic Acid; Cathartics; Citrates; Citric Acid; Colonoscopy; Colorectal Neoplasms; Defecatio | 2015 |
A comparison of cathartics in pediatric ingestions.
Topics: Cathartics; Charcoal; Child, Preschool; Citrates; Citric Acid; Defecation; Double-Blind Method; Fece | 1995 |
Multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea.
Topics: Acute Disease; Child, Preschool; Citric Acid; Double-Blind Method; Fluid Therapy; Glucose; Humans; I | 2001 |
Does the administration of oral Bicitra before elective cesarean section affect the incidence of nausea and vomiting in the parturient?
Topics: Administration, Oral; Adult; Antacids; Cesarean Section; Citrates; Citric Acid; Female; Humans; Inci | 1991 |
4 other studies available for citric acid, anhydrous and Vomiting
| Article | Year |
|---|---|
An Infant With Vomiting, Constipation, and Weight Loss.
Topics: Calcitriol; Citric Acid; Constipation; Cysteamine; Cystinosis; Diagnosis, Differential; Fanconi Synd | 2020 |
Pediatric constipation in the emergency department: evaluation, treatment, and outcomes.
Topics: Abdominal Pain; Child; Child, Preschool; Citric Acid; Constipation; Diagnostic Imaging; Emergency Se | 2014 |
Tolerable infusion rate of citrate based on clinical signs and the electrocardiogram in conscious dogs.
Topics: Animals; Anticoagulants; Area Under Curve; Calcium; Citric Acid; Dogs; Dose-Response Relationship, D | 2006 |
Arginine: an indispensable amino acid for mature dogs.
Topics: Animals; Arginine; Body Weight; Citrates; Citric Acid; Dogs; Dose-Response Relationship, Drug; Femal | 1981 |